...
首页> 外文期刊>Translational research: the journal of laboratory and clinical medicine >Activated leukocyte cell adhesion molecule: a new paradox in cancer.
【24h】

Activated leukocyte cell adhesion molecule: a new paradox in cancer.

机译:活化白细胞粘附分子:癌症中的一个新悖论。

获取原文
获取原文并翻译 | 示例
           

摘要

The activated leukocyte cell adhesion molecule [ALCAM/CD166/melanoma metastasis clone D (MEMD)] is an immunoglobulin superfamily cell adhesion molecule. It is expressed developmentally in cells of all 3 embryonic lineages. The ALCAM expression is limited to subsets of cells in most adult tissues. ALCAM is localized at intercellular junctions in epithelium presumably as part of the adhesive complex that maintains tissue architecture. Over the past decade, alterations in expression of ALCAM have been reported in several human tumors (melanoma, prostate cancer, breast cancer, colorectal carcinoma, bladder cancer, and esophageal squamous cell carcinoma). This review summarizes the current knowledge of the role of ALCAM in malignancies.
机译:活化的白细胞粘附分子[ALCAM / CD166 /黑色素瘤转移克隆D(MEMD)]是免疫球蛋白超家族细胞粘附分子。它在所有3种胚胎谱系的细胞中发育表达。 ALCAM表达仅限于大多数成人组织中的细胞亚群。 ALCAM定位在上皮细胞间连接处,大概是维持组织结构的粘附复合物的一部分。在过去的十年中,已经报道了几种人类肿瘤(黑素瘤,前列腺癌,乳腺癌,结肠直肠癌,膀胱癌和食道鳞状细胞癌)中ALCAM表达的改变。这篇综述总结了ALCAM在恶性肿瘤中的作用的当前知识。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号